SCCPC is among the first few pharmaceutical corporations to obtain GMP certification in China. With state-of-the-art production facilities and test equipment, SCCPC is able to utilize the strengths of CCPC's Pharmaceutical Research Center and combine research and development resources from China and Taiwan.Currently, the main products include the following:antibiotics, cardiovascular drugs, gastrointestinal drugs, antihistamines, anti-inflammatory drugs and oral antidiabetic agents, as well as contact lens solutions and disinfectant products.

In 2014, SCCPC's new plant obtained the 2010 GMP and JGMP certifications.The new facility is highly automated and adopts more eco-friendly operations.

In setting its sights on the future, SCCPC actively pursues the values of passion, innovation, care and health; and continuously develops new drugs and improves product quality for the purpose of providing safe and effective medicine and meticulous service to patients and medical professionals.